175 related articles for article (PubMed ID: 37917215)
1. Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection.
Lu M; Yao Y; Liu H; Zhang X; Li X; Liu Y; Peng Y; Chen T; Sun Y; Gao G; Chen M; Zhao J; Zhang X; Yin C; Guo W; Yang P; Hu X; Rao J; Li E; Wong G; Yuan Z; Chiu S; Shan C; Lan J
JCI Insight; 2023 Dec; 8(23):. PubMed ID: 37917215
[TBL] [Abstract][Full Text] [Related]
2. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.
DeBuysscher BL; Scott D; Marzi A; Prescott J; Feldmann H
Vaccine; 2014 May; 32(22):2637-44. PubMed ID: 24631094
[TBL] [Abstract][Full Text] [Related]
3. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.
van Doremalen N; Lambe T; Sebastian S; Bushmaker T; Fischer R; Feldmann F; Haddock E; Letko M; Avanzato VA; Rissanen I; LaCasse R; Scott D; Bowden TA; Gilbert S; Munster V
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007462. PubMed ID: 31170144
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster.
DeBuysscher BL; de Wit E; Munster VJ; Scott D; Feldmann H; Prescott J
PLoS Negl Trop Dis; 2013; 7(1):e2024. PubMed ID: 23342177
[TBL] [Abstract][Full Text] [Related]
5. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.
Lo MK; Bird BH; Chattopadhyay A; Drew CP; Martin BE; Coleman JD; Rose JK; Nichol ST; Spiropoulou CF
Antiviral Res; 2014 Jan; 101():26-9. PubMed ID: 24184127
[TBL] [Abstract][Full Text] [Related]
6. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
[TBL] [Abstract][Full Text] [Related]
7. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
[TBL] [Abstract][Full Text] [Related]
8. Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.
Watanabe S; Yoshikawa T; Kaku Y; Kurosu T; Fukushi S; Sugimoto S; Nishisaka Y; Fuji H; Marsh G; Maeda K; Ebihara H; Morikawa S; Shimojima M; Saijo M
PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011851. PubMed ID: 38100536
[TBL] [Abstract][Full Text] [Related]
9. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.
Mire CE; Geisbert JB; Agans KN; Versteeg KM; Deer DJ; Satterfield BA; Fenton KA; Geisbert TW
Emerg Infect Dis; 2019 Jun; 25(6):1144-1152. PubMed ID: 31107231
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
Lo MK; Spengler JR; Welch SR; Harmon JR; Coleman-McCray JD; Scholte FEM; Shrivastava-Ranjan P; Montgomery JM; Nichol ST; Weissman D; Spiropoulou CF
J Infect Dis; 2020 May; 221(Suppl 4):S493-S498. PubMed ID: 31751453
[TBL] [Abstract][Full Text] [Related]
11. Antibody prophylaxis and therapy against Nipah virus infection in hamsters.
Guillaume V; Contamin H; Loth P; Grosjean I; Courbot MC; Deubel V; Buckland R; Wild TF
J Virol; 2006 Feb; 80(4):1972-8. PubMed ID: 16439553
[TBL] [Abstract][Full Text] [Related]
12. Immune responses in mice and pigs after oral vaccination with rabies virus vectored Nipah disease vaccines.
Shuai L; Ge J; Wen Z; Wang J; Wang X; Bu Z
Vet Microbiol; 2020 Feb; 241():108549. PubMed ID: 31928698
[TBL] [Abstract][Full Text] [Related]
13. Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
Monath TP; Nichols R; Tussey L; Scappaticci K; Pullano TG; Whiteman MD; Vasilakis N; Rossi SL; Campos RK; Azar SR; Spratt HM; Seaton BL; Archambault WT; Costecalde YV; Moore EH; Hawks RJ; Fusco J
PLoS Pathog; 2022 Jun; 18(6):e1010658. PubMed ID: 35759511
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates.
Isaacs A; Cheung STM; Thakur N; Jaberolansar N; Young A; Modhiran N; Bailey D; Graham SP; Young PR; Chappell KJ; Watterson D
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696372
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.
Loomis RJ; Stewart-Jones GBE; Tsybovsky Y; Caringal RT; Morabito KM; McLellan JS; Chamberlain AL; Nugent ST; Hutchinson GB; Kueltzo LA; Mascola JR; Graham BS
Front Immunol; 2020; 11():842. PubMed ID: 32595632
[TBL] [Abstract][Full Text] [Related]
16. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
[TBL] [Abstract][Full Text] [Related]
17. Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination.
Welch SR; Spengler JR; Genzer SC; Coleman-McCray JD; Harmon JR; Sorvillo TE; Scholte FEM; Rodriguez SE; O'Neal TJ; Ritter JM; Ficarra G; Davies KA; Kainulainen MH; Karaaslan E; Bergeron É; Goldsmith CS; Lo MK; Nichol ST; Montgomery JM; Spiropoulou CF
Sci Adv; 2023 Aug; 9(31):eadh4057. PubMed ID: 37540755
[TBL] [Abstract][Full Text] [Related]
18. Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection.
Lu M; Yao Y; Zhang X; Liu H; Gao G; Peng Y; Chen M; Zhao J; Zhang X; Yin C; Guo W; Yang P; Hu X; Rao J; Li E; Chen T; Chiu S; Wong G; Yuan Z; Lan J; Shan C
NPJ Vaccines; 2023 Nov; 8(1):170. PubMed ID: 37925490
[TBL] [Abstract][Full Text] [Related]
19. Status of vaccine research and development of vaccines for Nipah virus.
Satterfield BA; Dawes BE; Milligan GN
Vaccine; 2016 Jun; 34(26):2971-2975. PubMed ID: 26973068
[TBL] [Abstract][Full Text] [Related]
20. Differential Innate Immune Responses Elicited by Nipah Virus and Cedar Virus Correlate with Disparate In Vivo Pathogenesis in Hamsters.
Schountz T; Campbell C; Wagner K; Rovnak J; Martellaro C; DeBuysscher BL; Feldmann H; Prescott J
Viruses; 2019 Mar; 11(3):. PubMed ID: 30909389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
